Re: RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastasis model.
Mizutani
Kosuke
K
Department of Internal Medicine, University of Michigan School of Medicine, Comprehensive Cancer Center, United States.
Pienta
Kenneth J
KJ